This inventor holds 37 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 11 EPO patents, primarily in Opioid Receptor Antagonists. Top assignees: Theravance, Inc., Theravance Biopharma R&d IP, LLC. Active years: 2008-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Burlingame, CA (US) (2008 - 2013)
- Daly City, CA (US) (2012 - 2013)
- San Mateo, CA (US) (2012 - 2019)
Company Filing History:
Years Active: 2008-2019
Areas of Expertise:
Title: Daisuke Roland Saito: A Leader in Pharmaceutical Innovations
Introduction
Daisuke Roland Saito, based in San Mateo, CA, is an accomplished inventor with a remarkable portfolio of 37 patents. His significant contributions to pharmaceutical research have advanced the development of novel compounds with crucial therapeutic applications.
Latest Patents
Among his recent patents, Saito developed compounds known as 8-azabicyclo[3.2.1]octane, which serve as mu opioid receptor antagonists. This innovative invention introduces new compounds that may provide effective treatment options for conditions associated with mu opioid receptor activity. Additionally, he has patented inhibitors of the hepatitis C virus, offering new avenues for combating this challenging viral infection. These compounds and their associated pharmaceutical compositions highlight Saito's commitment to addressing critical health issues.
Career Highlights
Throughout his career, Daisuke Saito has made significant strides in the pharmaceutical industry, working with respected companies such as Theravance, Inc. and Theravance Biopharma R&D IP, LLC. His innovative spirit and technical expertise have led to substantial advancements in drug development, particularly in areas relating to pain management and viral infections.
Collaborations
Daisuke has collaborated with notable colleagues, including Daniel D. Long and Eric L. Stangeland. These partnerships reflect the collaborative nature of scientific research, underscoring the importance of teamwork in driving innovation and discovery within the pharmaceutical landscape.
Conclusion
Daisuke Roland Saito's dedication to innovation in the pharmaceutical sector is evident through his extensive patent portfolio and collaborative efforts. His work continues to impact the field, paving the way for new treatments and therapies that can improve patient outcomes and enhance quality of life. As he progresses in his career, it will be exciting to see how his future inventions contribute to advancements in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile